January 2021 FDA Recall Drug by Stanley Specialty Pharmacy Compounding And Wellness Center
D-0252-2021 - Superpotent Drug. Lidocaine higher concentration than listed

This Class II drug recall was voluntarily initiated by Stanley Specialty Pharmacy Compounding And Wellness Center on January 21, 2021 for the product Drug. The FDA reported the reason for recall as superpotent drug. lidocaine higher concentration than listed. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0252-2021

Reason for Recall
Superpotent Drug. Lidocaine higher concentration than listed
Initiated
01-21-2021
Reported
02-17-2021
Quantity
4400 grams (44 jars)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Stanley Specialty Pharmacy Compounding and Wellness Center
Distributed Nationwide in the USA
Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic ointment jar, Rx Only, Stanley Specialty Pharmacy 3120 Latrobe Dr. Suite 200 Charlotte, NC 28211

Batch or Lot Expiration Information

Lot# Lot: 195789 Exp. Apr. 17 2021